Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982272511> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W1982272511 endingPage "281" @default.
- W1982272511 startingPage "274" @default.
- W1982272511 abstract "Les antifongiques destinés au traitement des mycoses systémiques sont en nombre restreint : amphotéricine B, flucytosine et dérivés azolés. Cette dernière famille a constitué le seul progrès des deux dernières décennies et stimulé la recherche dans le domaine des antifongiques. Après le kétoconazole, deux triazoles : l'itraconazole et le fluconazole, actuellement en expérimentation, sont des innovations majeures. L'itraconazole semble être un bon anti-aspergillaire et le fluconazole un bon anti-levures, avec l'originalité, pour ce dernier, d'une forte diffusion dans le LCR et d'une élimination urinaire. Malgré ces progrès le pronostic des mycoses de l'immunodéprimé reste très sombre. L'arsenal thérapeutique est plus riche vis-à-vis des mycoses superficielles. De nombreux dérivés azolés et le ciclopiroxolamine ont été récemment commercialisés. Les allylamines et les morpholines sont deux nouvelles familles chimiques dont les dérivés sont expérimentés dans les dermatophytoses qui semblent leur meilleure indication. Only a small number of antifungal agents are available for the treatment of systemic mycosis : amphotericin B, flucytosine and azole derivatives. The later was the only advance during the last two decades, it bustered researches in antifungal chemotherapy. After ketoconazole, two triazoles : itraconazole and fluconazole are under experiment and represent two major innovations. Itraconazole has a good anti Aspergillus activity and fluconazole is active against yeasts, among its characteristics are marked CSF diffusion and urinary elimination. Despite these advances the prognosis of systemic mycoses in immunocompromised hosts remains very poor. More compounds are available for superficial mycosis. Numerous azole derivative and ciclopiroxolamine were recently marketed. Allylamine and morpholine derivatives represent two new chemical families. Their products are under experiment particularly in dermatophytosis which are their major indication." @default.
- W1982272511 created "2016-06-24" @default.
- W1982272511 creator A5071791274 @default.
- W1982272511 date "1988-05-01" @default.
- W1982272511 modified "2023-10-05" @default.
- W1982272511 title "Les antimycosiques en 1988" @default.
- W1982272511 cites W1502613544 @default.
- W1982272511 cites W1965845682 @default.
- W1982272511 cites W1971219620 @default.
- W1982272511 cites W1973361960 @default.
- W1982272511 cites W1973449055 @default.
- W1982272511 cites W1974741264 @default.
- W1982272511 cites W1993542692 @default.
- W1982272511 cites W2000173207 @default.
- W1982272511 cites W2001578253 @default.
- W1982272511 cites W2006096467 @default.
- W1982272511 cites W2013419362 @default.
- W1982272511 cites W2014907435 @default.
- W1982272511 cites W2016784435 @default.
- W1982272511 cites W2024745406 @default.
- W1982272511 cites W2037239476 @default.
- W1982272511 cites W2065464305 @default.
- W1982272511 cites W2087557835 @default.
- W1982272511 cites W2094878309 @default.
- W1982272511 cites W2104623370 @default.
- W1982272511 cites W2148014482 @default.
- W1982272511 cites W2158267732 @default.
- W1982272511 cites W2331445992 @default.
- W1982272511 cites W4231845387 @default.
- W1982272511 cites W4235522004 @default.
- W1982272511 cites W86174616 @default.
- W1982272511 doi "https://doi.org/10.1016/s0399-077x(88)80025-8" @default.
- W1982272511 hasPublicationYear "1988" @default.
- W1982272511 type Work @default.
- W1982272511 sameAs 1982272511 @default.
- W1982272511 citedByCount "0" @default.
- W1982272511 crossrefType "journal-article" @default.
- W1982272511 hasAuthorship W1982272511A5071791274 @default.
- W1982272511 hasBestOaLocation W19822725111 @default.
- W1982272511 hasConcept C185592680 @default.
- W1982272511 hasConcept C2777071850 @default.
- W1982272511 hasConcept C2777328456 @default.
- W1982272511 hasConcept C2779548794 @default.
- W1982272511 hasConcept C2779629538 @default.
- W1982272511 hasConcept C2780315139 @default.
- W1982272511 hasConcept C2780651595 @default.
- W1982272511 hasConcept C2781064554 @default.
- W1982272511 hasConcept C86803240 @default.
- W1982272511 hasConcept C89423630 @default.
- W1982272511 hasConceptScore W1982272511C185592680 @default.
- W1982272511 hasConceptScore W1982272511C2777071850 @default.
- W1982272511 hasConceptScore W1982272511C2777328456 @default.
- W1982272511 hasConceptScore W1982272511C2779548794 @default.
- W1982272511 hasConceptScore W1982272511C2779629538 @default.
- W1982272511 hasConceptScore W1982272511C2780315139 @default.
- W1982272511 hasConceptScore W1982272511C2780651595 @default.
- W1982272511 hasConceptScore W1982272511C2781064554 @default.
- W1982272511 hasConceptScore W1982272511C86803240 @default.
- W1982272511 hasConceptScore W1982272511C89423630 @default.
- W1982272511 hasIssue "5" @default.
- W1982272511 hasLocation W19822725111 @default.
- W1982272511 hasOpenAccess W1982272511 @default.
- W1982272511 hasPrimaryLocation W19822725111 @default.
- W1982272511 hasRelatedWork W1976860535 @default.
- W1982272511 hasRelatedWork W1989672103 @default.
- W1982272511 hasRelatedWork W2004150955 @default.
- W1982272511 hasRelatedWork W2006740157 @default.
- W1982272511 hasRelatedWork W2048574241 @default.
- W1982272511 hasRelatedWork W2140536918 @default.
- W1982272511 hasRelatedWork W2172042863 @default.
- W1982272511 hasRelatedWork W2313213222 @default.
- W1982272511 hasRelatedWork W2526078137 @default.
- W1982272511 hasRelatedWork W31001855 @default.
- W1982272511 hasVolume "18" @default.
- W1982272511 isParatext "false" @default.
- W1982272511 isRetracted "false" @default.
- W1982272511 magId "1982272511" @default.
- W1982272511 workType "article" @default.